Bioterrorism: Guidelines for Medical and Public Health Management is the most credible and up-to-date new book on the recognition, diagnosis, and management of infections caused by agents used in bioterror weapons. Edited by leading experts in the field, including Donald Henderson, MD, MPH, the Director of the US Office of Public Health Preparedness, this valuable clinical resource is the only book providing guidelines and recommendations for the medical and public health community following a bioterrorist attack.

These guidelines have been written by the Working Group on Civilian Biodefense, which includes the nation's medical experts in academic, research, government, military, public health, and emergency management institutions and agencies.

Each chapter has undergone a rigorous peer-review process and is considered the definitive publication on the medical and public health management of infections caused by bioterrorist weapons.

The text addresses specific diseases and syndromes associated with a bioterrorist attack that were identified as of greatest potential threat to the civilian population, including anthrax, smallpox, plague, botulinum toxin, and tularemia.

Each disease and syndrome follows the same logical and practically grounded order:

• History and potential as a biological weapon
• Epidemiology and microbiology
• Pathogenesis and clinical presentation
• Diagnosis
• Treatment
• Prevention and prophylaxis
• Infection control and decontamination
• Future research agendas

This valuable resource also includes seminal articles describing the diagnosis and management of the victims and survivors of the first bioterrorist attack with anthrax in the United States. Also included is an article on the principles of quarantine and isolation, a useful discussion for the medical, public health, and policy communities.

Physicians and other front-line clinicians, emergency response workers, public health officials, and policymakers will find this to be the most credible and up-to-date book on the recognition, diagnosis, and management of infections caused by agents used in bioterrorist weapons.

Why Understanding Biological Weapons Matters to Medical and Public Health Professionals
Bioterrorism on the Home Front: A New Challenge for American Medicine
Clinical Presentation of Inhalational Anthrax Following Bioterrorism Exposure: Report of 2 Surviving Patients
Death Due to Bioterrorism-Related Inhalational Anthrax: Report of 2 Patients
Bioterrorism Preparedness and Response: Clinicians and Public Health Agencies as Essential Partners
Fatal Inhalational Anthrax With Unknown Source of Exposure in a 61-Year-Old Woman in New York City
Fatal Inhalational Anthrax in a 94-Year-Old Connecticut Woman
Cutaneous Anthrax Associated With Microangiopathic Hemolytic Anemia and Coagulopathy in a 7-Month-Old Infant
Anthrax as a Biological Weapon: Updated Recommendations for Management
Smallpox as a Biological Weapon
Plague as a Biological Weapon
Botulinum Toxin as a Biological Weapon
Tularemia as a Biological Weapon
Hemorrhagic Fever Viruses as Biological Weapons
Large-Scale Quarantine Following Biological Terrorism in the United States